A marked change in the odds ratio of serum FGF21 at hypertension risk occurred in the 113.3–544.6 pg/mL range (ln-transformed FGF21, 4.7–6.3; estimate from the spline). This evidence concerns the gene FGF21 and hypertensive disorder.